---
title: "STRATA CRITICAL MED INC C/WTS 07/05/2026 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 67.38 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285364020.md"
datetime: "2026-05-06T11:11:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285364020.md)
  - [en](https://longbridge.com/en/news/285364020.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285364020.md)
generator: "portal-rs"
---

# STRATA CRITICAL MED INC C/WTS 07/05/2026 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 67.38 M

Revenue: As of FY2026 Q1, the actual value is USD 67.38 M.

EPS: As of FY2026 Q1, the actual value is USD 0.03.

EBIT: As of FY2026 Q1, the actual value is USD -3.447 M.

The provided reference, a Form 8-K filing by STRATA CRITICAL MEDICAL, INC., announces a press release detailing financial results for the first quarter ended March 31, 2026. However, the actual financial results, operational metrics, or any forward-looking guidance are not contained within this document itself. These details are stated to be in Exhibit 99.1 (Press Release), which is incorporated by reference but not provided in the given text for analysis. Therefore, no specific financial or operational metrics or outlook can be extracted from the provided content.

### Related Stocks

- [SRTAW.US](https://longbridge.com/en/quote/SRTAW.US.md)

## Related News & Research

- [JOYY beats top-line and bottom-line estimates; gives FY 2026 outlook](https://longbridge.com/en/news/296985959.md)
- [Cybeats updates financial calendar, schedules Q2 fiscal 2026 results webcast](https://longbridge.com/en/news/297086797.md)
- [Systemair corrects dividend record date to Aug. 31, 2026 from Sept. 31 error](https://longbridge.com/en/news/297344953.md)
- [Cemat publishes H1 2026 interim report](https://longbridge.com/en/news/297006906.md)
- [Gudang Garam schedules annual public expose on January-June 2026 results](https://longbridge.com/en/news/297131461.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**